Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy

被引：0
|
作者：
JLF Costa
J Ferreira
C Teles
F Gutierrez
A Mesquita
RC Costa-Filho
机构：
[1] Hospital Pró-Cardíaco,
来源：
Critical Care | / 11卷 / Suppl 3期
关键词：
Enoxaparin; Unfractionated Heparin; Continuous Renal Replacement Therapy; Gastric Lesion; Filter Performance;
D O I：
10.1186/cc5843
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement
    Yoshida, Kakunoshin
    Wada, Hideo
    Hasegawa, Masahiro
    Wakabayashi, Hiroki
    Ando, Honami
    Oshima, Seika
    Matsumoto, Takeshi
    Shimokariya, Yuji
    Noma, Katsura
    Yamada, Norikazu
    Uchida, Atsumasa
    Nobori, Tsutomu
    Sudo, Akihiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (04) : 355 - 360
  • [42] Anti-Xa based dosing of enoxaparin in hematopoietic stem cell transplant and adoptive cell therapy patients: A single center experience
    Jizzini, Mazen
    Akhtar, Othman Salim
    Atwood, Kris
    Ji, Wenyan
    Pleskow, Jordan
    Bat, Taha
    Balderman, Sophia
    [J]. THROMBOSIS RESEARCH, 2022, 211 : 6 - 9
  • [43] Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagents
    Smahi, Motalib
    De Pooter, Neila
    Hollestelle, Martine J.
    Toulon, Pierre
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) : 2613 - 2621
  • [44] Dose determinants in continuous renal replacement therapy
    Clark, WR
    Turk, JE
    Kraus, MA
    Gao, DY
    [J]. ARTIFICIAL ORGANS, 2003, 27 (09) : 815 - 820
  • [45] SUSTAINED INCREASE IN ANTI-XA ACTIVITY BY LOW-DOSE HEPARIN IN MEDICAL PATIENTS
    LOWE, G
    BELCH, J
    REGAN, K
    FORBES, C
    PRENTICE, C
    [J]. THROMBOSIS AND HAEMOSTASIS, 1982, 47 (03) : 296 - 296
  • [46] Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis
    Heizmann, M
    Baerlocher, GM
    Steinmann, F
    Horber, FF
    Wuillemin, WA
    [J]. THROMBOSIS RESEARCH, 2002, 106 (4-5) : 179 - 181
  • [47] ANTI-XA MONITORING OF WEIGHT-BASED ENOXAPARIN FOR VTE PROPHYLAXIS IN CRITICALLY ILL TRAUMA PATIENTS
    Taylor, Ashley
    Huang, Ellen
    Waller, Jennifer
    White, Cassandra
    Robinson, Tim
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [48] Anti-xa activity and outcomes in patients undergoing elective percutaneous coronary intervention with intravenous enoxaparin: The STEEPLE trial
    Montalescot, G
    Steinhubl, S
    Cohen, M
    Desmet, W
    Macaya, C
    White, H
    Gallo, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 36B - 36B
  • [49] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    [J]. THROMBOSIS RESEARCH, 1997, 85 (03) : 259 - 265
  • [50] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (Enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1172 - P1172
12345